Risks and benefits of available treatments for adult ADHD.

Jeffrey H. Newcorn

Research output: Contribution to journalComment/debate

3 Scopus citations


Several pharmacotherapeutic options, both FDA-approved and off-label, exist for the treatment of adult ADHD. The most commonly used agents include several stimulants and atomoxetine, which have demonstrated significant, though similar, efficacy for ADHD versus placebo. Treatment should be selected according to patient comorbidity profiles, cardiovascular risks, and risk of abuse of prescription medications. In this activity, treatments for ADHD with and without comorbidity are discussed, including mechanisms of action, safety risks, and the potential for substance abuse. Implementing psychosocial education in conjunction with pharmacotherapy is recommended.

Original languageEnglish
Pages (from-to)e12
JournalJournal of Clinical Psychiatry
Issue number3
StatePublished - Mar 2011


Dive into the research topics of 'Risks and benefits of available treatments for adult ADHD.'. Together they form a unique fingerprint.

Cite this